Inactivating mutations of FBXW7 are observed in 2.5% of CLL cases (36), suggesting a role of genetic aberrations in the NOTCH1-ICD degradation machinery in CLL pathogenesis (32, 140). Here, GNPTAB is linked to B-cell chronic lymphocytic leukemia.